https://www.selleckchem.com/pr....oducts/crt-0105446.h
elays between symptom onset and first injection led to less optimistic vision gains and were associated with higher incidence of negative sequelae. Patients with RVO demonstrating poor initial visual acuity showed visual and anatomic benefit with anti-VEGF therapy, most often observed shortly after initiation of treatment. In CRVO patients, even minor delays between symptom onset and first injection led to less optimistic vision gains and were associated with higher incidence of negative sequelae.The use of videoconferencing technol
Like
Comment
Share
